Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma

We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dei-Adomakoh, Yvonne A, Afriyie-Mensah, Jane S, Gbadamosi, Hafisatu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ghana Medical Association 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042802/
https://www.ncbi.nlm.nih.gov/pubmed/33883778
http://dx.doi.org/10.4314/gmj.v54i4.12
_version_ 1783678191506817024
author Dei-Adomakoh, Yvonne A
Afriyie-Mensah, Jane S
Gbadamosi, Hafisatu
author_facet Dei-Adomakoh, Yvonne A
Afriyie-Mensah, Jane S
Gbadamosi, Hafisatu
author_sort Dei-Adomakoh, Yvonne A
collection PubMed
description We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma and germ cell tumors. BIP has a significant mortality rate if detected late and a high index of suspicion is required in all patients on bleomycin-based therapies with sudden onset of respiratory symptoms.
format Online
Article
Text
id pubmed-8042802
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ghana Medical Association
record_format MEDLINE/PubMed
spelling pubmed-80428022021-04-20 Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma Dei-Adomakoh, Yvonne A Afriyie-Mensah, Jane S Gbadamosi, Hafisatu Ghana Med J Case Report We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma and germ cell tumors. BIP has a significant mortality rate if detected late and a high index of suspicion is required in all patients on bleomycin-based therapies with sudden onset of respiratory symptoms. Ghana Medical Association 2020-12 /pmc/articles/PMC8042802/ /pubmed/33883778 http://dx.doi.org/10.4314/gmj.v54i4.12 Text en Copyright © The Author(s). https://creativecommons.org/licenses/by/4.0/This is an Open Access article under the CC BY license.
spellingShingle Case Report
Dei-Adomakoh, Yvonne A
Afriyie-Mensah, Jane S
Gbadamosi, Hafisatu
Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title_full Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title_fullStr Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title_full_unstemmed Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title_short Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
title_sort bleomycin-induced pneumonitis in a young ghanaian male with hodgkin's lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042802/
https://www.ncbi.nlm.nih.gov/pubmed/33883778
http://dx.doi.org/10.4314/gmj.v54i4.12
work_keys_str_mv AT deiadomakohyvonnea bleomycininducedpneumonitisinayoungghanaianmalewithhodgkinslymphoma
AT afriyiemensahjanes bleomycininducedpneumonitisinayoungghanaianmalewithhodgkinslymphoma
AT gbadamosihafisatu bleomycininducedpneumonitisinayoungghanaianmalewithhodgkinslymphoma

Ejemplares similares